A Study to Investigate Leramistat in Patients With IPF

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 30, 2023

Primary Completion Date

February 27, 2024

Study Completion Date

March 14, 2024

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

Leramistat

Drug: Leramistat

DRUG

Placebo

Placebo comparator

Trial Locations (57)

20007

MedStar Georgetown University Hospital, Washington D.C.

33165

Reliant Medical Research, Miami

33175

US Associates in Research Inc, Miami

93701-2302

UCSF Fresno, Fresno

80206-2761

National Jewish Health Main Campus, Denver

33609-3589

GCP Clinical Research, LLC, Tampa

GCP Clinical Research, Tampa

31201-8334

Southern Medical Research, LLC, Macon

60649-4718

GenHarp Clinical Solutions, Chicago

47303-3432

IU Health Ball Memorial Physicians Pulmonary and Critical Care Medicine, Muncie

70433-2353

Benchmark Research - Covington - HyperCore - PPDS, Covington

21201-1544

University of Maryland Medical Center, Baltimore

21044-3081

Howard County Center for Lung and Sleep Medicine, LLC, Columbia

21045-5422

Howard County Center for Lung and Sleep Medicine, LLC, Columbia

07087-3375

Hudson County Clinical Trials Research Center, Union City

27710-4000

Duke University Medical Center, Durham

27103-4029

Southeastern Research Center, Winston-Salem

75246-2073

Baylor Scott and White Health - Advanced Lung Disease Specialists - Dallas, Dallas

75069-1898

Metroplex Pulmonary and Sleep Medicine Center-4833 Medical Center Dr, McKinney

Metroplex Pulmonary and Sleep Medicine Centre 4833 Medical Center Dr, McKinney

84108-1257

University of Utah - PPDS, Salt Lake City

Unknown

Hopital Nord AP-HM, Marseille

Hôpital Pasteur II, Nice

Hôpital Européen Georges Pompidou, Paris

Hopital Robert Schuman, Vantoux

Zentralklinik Bad Berka GmbH, Bad Berka

Klinikum Köln-Merheim, Cologne

Ruhrlandklinik, Essen

IKF Pneumologie, Frankfurt am Main

Universitätsklinikum Gießen und Marburg GmbH, Giessen

Universitatsklinikum Halle (Saale), Halle

Universitatsklinikum Leipzig, Leipzig

Universitatsklinikum Schleswig-Holstein - Kiel, Lübeck

University Hospital of Alexandroupolis, Alexandroupoli

Evangelismos General Hospital of Athens, Athens

"General Hospital of Diseases Thoracos of Athens Sotiria", Athens

University General Hospital of Heraklion, Heraklion

University General Hospital of Ioannina, Ioannina

University General Hospital of Larissa, Larissa

Georgios Papanikolaou General Hospital of Thessaloniki, Thessaloniki

Semmelweis Egyetem, Budapest

Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz, Székesfehérvár

Lady Davis Carmel Medical Center, Haifa

Rambam Medical Center - PPDS, Haifa

Kaplan Medical Center, Rehovot

Tel Aviv Sourasky Medical Center - PPDS, Tel Aviv

Azienda Ospedaliero Universitaria Policlinico Vittorio Emanuele, Catania

Azienda Ospedaliera Universitaria Careggi, Florence

Azienda Ospedaliero Universitaria Di Modena Policlinico, Modena

Fondazione Policlinico Universitario A Gemelli-Rome, Roma

Azienda Ospedaliera Universitaria Senese, Siena

Hospital Puerta del Mar, Cadiz

Hospital Clinico Universitario de Valencia, Valencia

Royal Brompton Hospital, London

University College Hospital, London

North Manchester General Hospital - PPDS, Manchester

Walsall Manor Hospital, Walsall

Sponsors
All Listed Sponsors
lead

Modern Biosciences Ltd

INDUSTRY

NCT05951296 - A Study to Investigate Leramistat in Patients With IPF | Biotech Hunter | Biotech Hunter